Comprehensive Metabolic Panel (CMP) Testing Market is Expected to Reach USD 22.97 Billion By 2028 - Reports and Data

The global Comprehensive Metabolic Panel (CMP) Testing market size is expected to reach USD 22.97 billion by 2028 and register a CAGR of 7.8% according to the latest report by Reports and Data. Rising prevalence of chronic diseases, such as kidney diseases, diabetes, liver dysfunctions, and growing research on developing innovative products are key factors driving global market revenue growth.

Comprehensive metabolic panel testing is a blood test that measures 14 different types of substances for analyzing body mechanisms and various parameters, such as kidney and liver health, blood protein and sugar levels, body fluid balance, and electrolyte levels. Increasing cases of chronic conditions and rising prevalence of lifestyle-associated diseases such as obesity or hypertension due to smoking, lack of exercise, and sedentary lifestyle are primarily boosting demand for comprehensive metabolic panel testing systems. In addition, growing adoption of point-of-care CMP testing and rising number of biopsy processes are expected to further enhance revenue growth. Moreover, increasing initiatives taken by government to create awareness about diseases and treatment for chronic diseases are fueling market growth.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4021

However, factors, such as implementation of strict regulations and high possibility of fast results due to dearth of skilled professionals, are expected to hamper growth of the global comprehensive metabolic panel testing market during the forecast period.

Some key highlights in the report:

Among the disease segments, the kidney segment is projected to account for largest market growth during the forecast period. Rising prevalence of kidney diseases, high blood pressure, diabetes, and increasing need for detecting these diseases at an early stage are key factors boosting market growth.

In context to end user, the point of care segment is expected to register fastest revenue CAGR throughout the forecast period owing to factors such as rapid diagnosis, ease of operation, and less requirement of samples.

North America is expected to account for largest market share in the global comprehensive metabolic panel testing market during the forecast period. High revenue share is attributable to increasing adoption of CMP testing, rising prevalence of various infectious and chronic diseases, well-established healthcare systems and infrastructure, and presence of significant key players.

Asia Pacific is expected to account for fastest revenue growth between 2021 and 2028 due to rising prevalence of kidney disorders and diabetes, rising disposable income, and increasing geriatric population.

Europe is expected to account for high revenue growth over the forecast period due to increasing geriatric population, high prevalence of kidney diseases, and access to latest healthcare facilities.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4021

Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.

The growing popularity of over-the-counter medications driving market growth

Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.

Restriction on product launches and R&D activities to hamper the market growth

The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.

Top Companies Profiled in the Report:

Abbott Laboratories, Quest Diagnostics Incorporated, Sonic Healthcare, Laboratory Corporation of America Holdings, ARUP Laboratories, CENTOGENE AG, SYNLAB International GmbH, TCG Corp, Scion Lab Services, LLC, UNIPATH

Comprehensive Metabolic Panel (CMP) Testing Market Segmentation:

Disease Outlook (Revenue, USD Billion, 2018 - 2028)

Kidney Disease
Liver Disease
Diabetes
Others

Test Type Outlook (Revenue, USD Billion, 2018 - 2028)

Electrolytes
Proteins
Kidney Tests
Glucose
Liver Functional Tests
Others

End User Outlook (Revenue, USD Billion, 2018 - 2028)

Laboratories
PoC (Point of Care)

Regional Outlook:

North America (U.S., Canada, Mexico)
Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
Latin America (Brazil, Rest of LATAM)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

Frequently asked questions addressed in the report:

What is the revenue growth rate of the global Comprehensive Metabolic Panel (CMP) Testing market over the forecast period?
What are the major factors driving the growth of the Global Comprehensive Metabolic Panel (CMP) Testing Market?
What are the key challenges impacting the global Comprehensive Metabolic Panel (CMP) Testing market growth?
What are the outcomes of the SWOT Analysis and Porter's Five Forces Analysis conducted in the report?

Request customization on the report @ https://www.reportsanddata.com/request-customization-form/4021

Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.

Explore Latest Trending Research Reports By Reports and Data:

Cerebrospinal Fluid (CSF) Management Market @ https://www.biospace.com/article/cerebrospinal-fluid-csf-management-market-is-expected-to-reach-usd-2-31-billion-in-2028-/

Immunomodulators Market @ https://www.biospace.com/article/immunomodulators-market-growth-prospects-latest-trend-analysis-development-and-forecast-2027/

Acute Respiratory Distress Syndrome (ARDS) Market @ https://www.biospace.com/article/acute-respiratory-distress-syndrome-ards-market-growth-report-size-share-and-rising-demand-till-2027/

Oncology Molecular Diagnostics Market @ https://www.biospace.com/article/oncology-molecular-diagnostics-market-analysis-detailed-growth-insights-till-2027/

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.